Latest Breaking News On - Prnewswire deka biosciences - Page 1 : vimarsana.com

Deka Biosciences Adds Industry Veterans to its Executive Leadership Team and Board of Directors

/PRNewswire/ Deka Biosciences ("Deka") today announced the appointments of Stanley Frankel, M.D., FACP, as senior clinical advisor, interim chief medical.

New yorkUnited statesColumbia universitySutro biopharmaStuart chaffeePrnewswire deka biosciencesJohn mummStanley frankelMedimmune astrazenecaDeka diakineAtlas ventureNorthwestern university medical schoolCollege of physiciansHarvard collegeClinical researchWharton school of the university pennsylvania

Deka Biosciences Adds Industry Veterans to its Executive Leadership Team and Board of Directors

Deka Biosciences Adds Industry Veterans to its Executive Leadership Team and Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesColumbia universityMedimmune astrazenecaDeka diakineSutro biopharmaStuart chaffeePrnewswire deka biosciencesStanley frankelDeka biosciencesJohn mummClinical researchAtlas ventureNorthwestern university medical schoolWharton school of the university pennsylvaniaCollege of physicians

Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)

Deka Biosciences Announces First-in-Human Dose in Phase 1 Clinical Trial of DK210 (EGFR)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire deka biosciencesJohn mummDeka biosciencesClinical director

Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application

/PRNewswire/ Deka Biosciences ("Deka"), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory diseases, today.

United statesJohn mummPrnewswire deka biosciencesDrug administrationDeka biosciencesHealth care amp hospitalsMedical pharmaceuticalsClinical trials amp medical discoveriesFda approvalNew products amp services

Deka Biosciences Appoints Chief Medical Officer and Vice President of Clinical Operations

/PRNewswire/ Deka Biosciences ("Deka"), a biotech company focused on the development of novel cytokine therapies to treat cancer and inflammatory diseases,.

John mummCharlotte moserDeb kientopPrnewswire deka biosciencesUniversity of wisconsinNanocan therapeutics corporationChief medical officerVice presidentChief executive officerChief scientificSenior vice presidentOncology strategyDeka biosciences